NCT07146178

Brief Summary

The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments? Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery. Participants will:

  • Receive ERAS protocol during the hospitalization
  • Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7
  • Visit the hospital at one week and one month after discharge
  • Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2025Oct 2026

First Submitted

Initial submission to the registry

July 31, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

July 31, 2025

Last Update Submit

August 21, 2025

Conditions

Keywords

Enhanced recovery after surgerybio-signal monitoring

Outcome Measures

Primary Outcomes (9)

  • Quality of Recovey-15, Korean version (QoR-15K)

    This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

    on 24 hours postoperatively

  • Quality of Recovey-15, Korean version (QoR-15K)

    This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

    one week after hospital discharge

  • Quality of Recovey-15, Korean version (QoR-15K)

    This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

    one month after hospital discharge

  • The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)

    WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.

    on 24 hours postoperatively

  • The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)

    WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.

    one week after hospital discharge

  • The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)

    WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.

    one month after hospital discharge

  • EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)

    EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.

    on 24 hours postoperatively

  • EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)

    EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.

    1 week after hospital discharge

  • EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)

    EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.

    1 month after hospital discharge

Secondary Outcomes (7)

  • Pain (Visual analogue scale)

    on 24 hours postoperatively

  • Pain (Visual analogue scale)

    1 week after hospital discharge

  • Pain (Visual analogue scale)

    1 month after hospital discharge

  • Length of stay

    throughout hospitalization, expected to be 2-3 days

  • Total in-hospital opioid consumption

    throughout hospitalization, expected to be 2-3 days

  • +2 more secondary outcomes

Other Outcomes (1)

  • Heart rate variability

    From discharge day to one month after discharge

Study Arms (2)

ERAS

EXPERIMENTAL
Procedure: Enhanced Recovery After Surgery

Conventional

ACTIVE COMPARATOR
Procedure: Usual Care

Interventions

1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a foley catheter removal on ward arrival * Soft meal 4 housr after surgery * General diet 8 hours after surgery

Also known as: ERAS
ERAS
Usual CarePROCEDURE

1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery * Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after the surgery * Soft meal after gas out * General diet after one soft meal

Conventional

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 20 and 70 years
  • Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia
  • Use of an Android smartphone

You may not qualify if:

  • American Society of Anesthesiologists(ASA) physical status classification IV or higher
  • Body Mass Index (BMI) 35 or higher
  • Presence of diabetic autonomic neuropathy
  • History of esophageal hiatal hernia or delayed stomach discharge
  • Known allergy to local anesthesia
  • Participantion in other trials that may affect study outcomes
  • Inability to complete questionnaires (e.g., due to cognitive impairment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, 26426, South Korea

Location

MeSH Terms

Interventions

Enhanced Recovery After Surgery

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, Operative

Central Study Contacts

Seung Woo Song, M.D., Ph.D.

CONTACT

Hunju Lee, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

July 31, 2025

First Posted

August 28, 2025

Study Start

September 1, 2025

Primary Completion

October 1, 2025

Study Completion (Estimated)

October 1, 2026

Last Updated

August 28, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations